PERFLUOROHEXYLOCTANE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for perfluorohexyloctane and what is the scope of freedom to operate?
Perfluorohexyloctane
is the generic ingredient in one branded drug marketed by Bausch And Lomb Inc and is included in one NDA. There are six patents protecting this compound. Additional information is available in the individual branded drug profile pages.Perfluorohexyloctane has one hundred and seven patent family members in sixteen countries.
One supplier is listed for this compound.
Summary for PERFLUOROHEXYLOCTANE
| International Patents: | 107 |
| US Patents: | 6 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 52 |
| Clinical Trials: | 5 |
| Patent Applications: | 157 |
| What excipients (inactive ingredients) are in PERFLUOROHEXYLOCTANE? | PERFLUOROHEXYLOCTANE excipients list |
| DailyMed Link: | PERFLUOROHEXYLOCTANE at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for PERFLUOROHEXYLOCTANE
Generic Entry Date for PERFLUOROHEXYLOCTANE*:
Constraining patent/regulatory exclusivity:
NEW CHEMICAL ENTITY Dosage:
SOLUTION/DROPS;OPHTHALMIC |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for PERFLUOROHEXYLOCTANE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Gordon Schanzlin New Vision | Phase 4 |
| Novaliq GmbH | Phase 3 |
| Bausch & Lomb Incorporated | Phase 3 |
US Patents and Regulatory Information for PERFLUOROHEXYLOCTANE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bausch And Lomb Inc | MIEBO | perfluorohexyloctane | SOLUTION/DROPS;OPHTHALMIC | 216675-001 | May 18, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
| Bausch And Lomb Inc | MIEBO | perfluorohexyloctane | SOLUTION/DROPS;OPHTHALMIC | 216675-001 | May 18, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bausch And Lomb Inc | MIEBO | perfluorohexyloctane | SOLUTION/DROPS;OPHTHALMIC | 216675-001 | May 18, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bausch And Lomb Inc | MIEBO | perfluorohexyloctane | SOLUTION/DROPS;OPHTHALMIC | 216675-001 | May 18, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bausch And Lomb Inc | MIEBO | perfluorohexyloctane | SOLUTION/DROPS;OPHTHALMIC | 216675-001 | May 18, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bausch And Lomb Inc | MIEBO | perfluorohexyloctane | SOLUTION/DROPS;OPHTHALMIC | 216675-001 | May 18, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for PERFLUOROHEXYLOCTANE
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Denmark | 3355990 | ⤷ Sign Up | |
| China | 108348777 | 半氟化化合物和其组合物 (SEMIFLUORINATED COMPOUNDS AND THEIR COMPOSITIONS) | ⤷ Sign Up |
| Poland | 3355990 | ⤷ Sign Up | |
| European Patent Office | 4342537 | COMPOSITIONS D'ALCANE SEMIFLUORÉ (SEMIFLUORINATED ALKANE COMPOSITIONS) | ⤷ Sign Up |
| South Korea | 20150054996 | 부분불소화 알칸의 혼합물을 포함하는 조성물 (COMPOSITIONS COMPRISING MIXTURES OF SEMIFLUORINATED ALKANES) | ⤷ Sign Up |
| Spain | 2770398 | ⤷ Sign Up | |
| >Country | >Patent Number | >Title | >Estimated Expiration |
